TECVAYLI

Indicated For

relapsed or refractory multiple myeloma

About This Medication

# Johnson & Johnson Patient Assistance Program Patient Guide: How to Get TECVAYLI (teclistamab-cqyv) at Low or No Cost TECVAYLI (teclistamab-cqyv) is a prescription medication used to treat adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This guide explains the **Johnson & Johnson Patient Assistance Program**, which provides TECVAYLI at no cost for up to one year to eligible uninsured patients facing financial hardship.[1][6] ## About TECVAYLI and Why Assistance Matters **TECVAYLI** is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager administered via subcutaneous injection. It works by redirecting the patient's T cells to target and kill multiple myeloma cells. Multiple myeloma is a type of blood cancer that affects plasma cells in the bone marrow, often leading to symptoms like bone pain, fatigue, anemia, and frequent infections. For patients who have progressed through multiple treatments, TECVAYLI offers a targeted option, but its high cost—often tens of thousands per dose—makes it inaccessible without support.[1] The Johnson & Johnson Patient Assistance Program bridges this gap by offering free medication to those who qualify, ensuring treatment continuity without financial burden. This program is part of J&J's commitment to patient access, partnering with resources like J&J withMe for comprehensive support.[4][9] ## Who Qualifies for the Program? Eligibility focuses on uninsured patients experiencing financial need. Key criteria include: - **Residency**: U.S. residents or Puerto Rico. - **Insurance Status**: Primarily for uninsured patients; some Medicare Part D patients may qualify if they spend more than 4% of gross annual household income on prescriptions and meet other rules (e.g., not eligible for Low-Income Subsidy if income ≤150% FPL).[3][7] - **Income**: Household income must meet program guidelines, though specific Federal Poverty Level (FPL) thresholds are not publicly detailed here. Best practice is to provide proof like a recent 1040 tax return.[2] - **Prescription**: Valid outpatient prescription from a U.S.-licensed physician for TECVAYLI.[7] - **Duration**: Up to one year of free medication; reapplication required annually.[1][6] Patients with commercial, employer-sponsored, or government insurance that doesn't fully cover needs may also explore options, but the core program targets uninsured individuals.[8][9] ## Income Eligibility Breakdown Exact income thresholds vary by household size and are assessed during application, often up to a percentage of the FPL (typically 400-500% in similar programs, but confirm via phone). Include proof of income for fastest processing. | Household Size | Estimated Max Income (Example based on 400% FPL)* | Notes | |---------------|---------------------------------------------------|-------| | 1 (Individual) | ~$60,000 | Provide 1040 tax return [2] | | 2 (Couple) | ~$81,000 | Adjusts for dependents [7] | | 3 | ~$102,000 | Puerto Rico: Additional financial docs [2] | | 4 | ~$122,000 | Call for exact current FPL [3] | *Estimates for illustration; actual limits determined by J&J. Contact 833-742-0791 for precise figures.[2][3] ## Insurance Requirements The program is designed for **uninsured patients** without prescription coverage. If you have insurance: - Submit copies of front/back of all cards (medical, pharmacy).[2] - Medicare Part D: Prove >4% income spent on drugs; may need EOB or pharmacy report. LIS-ineligible if >150% FPL.[3][8] Underinsured patients with gaps in coverage may qualify if needs aren't met.[9] ## Step-by-Step Application Process 1. **Gather Info**: Collect insurance details (if any), healthcare provider info, and income proof (e.g., 1040 tax return).[2] 2. **Download Form**: Get the Patient Assistance Enrollment Form from JJPatientAssistance.com or portal.jnjwithme.com.[2][5] 3. **Complete Sections**: Patient/caregiver fills pages 1-2; review/sign Consent (pg 4-7) and Authorization Forms (or online at JJPatientAssistance.com/Consent and /PA).[2][5] 4. **Doctor's Role**: Have your healthcare provider complete/sign page 3 for TECVAYLI (one per med).[2] 5. **Submit**: - **Online/Upload**: Via portal.jnjwithme.com/patient-assistance/enroll.[1] - **Fax**: 833-512-0497.[3][5] - **Phone Help**: Call 833-742-0791 (M-F, 8AM-8PM ET).[2] 6. **Track Status**: J&J notifies you and your doctor on eligibility.[3] Incomplete apps delay processing—double-check checklist![2] ## Timeline and Delivery Processing time isn't specified but aim for complete submission to avoid delays. Once approved, TECVAYLI is **shipped directly to your home** at no cost.[1] Expect updates via phone/email. Coverage lasts up to 12 months; **reauthorization required** annually—resubmit form with updated info.[1][6] ## Alternatives if Denied or Ineligible - **J&J withMe/Janssen CarePath**: Cost support for commercially insured, free trials, foundation referrals.[4][9] - **Medicine Assistance Tool (MAT)**: Search 100s of programs at MAT.org.[4] - **Simplefill**: Helps enroll in J&J or alternatives; call (877)386-0206.[7] - **State Programs**: Check for multiple myeloma-specific aid. - **Reapply**: Fix issues (e.g., missing docs) and resubmit.[2] ## Disclaimer This guide is for informational purposes based on publicly available data as of 2026. Eligibility, terms, and availability can change—always verify with J&J at 833-742-0791 or official sites. Not medical advice; consult your doctor for TECVAYLI suitability. J&J not liable for application outcomes. Program provides medication only, not treatment/administration costs.[2][5]

Program information last verified: March 30, 2026